NEW research from the University of California has found that a 15-day course of Paxloid, a widely available antiviral, may help ease symptoms of long COVID.
Five out of 13 patients (38%) showed sustained improvement, while nearly all benefited in the short-term, with relief experienced for persistent symptoms like respiratory issues, fatigue, brain fog, and body aches.
"This is not a silver bullet, but it may help a lot of people in a meaningful way," said the study's lead author and an epidemiologist, Dr Alison Cohen - read the paper here.
The above article was sent to subscribers in Pharmacy Daily's issue from 09 Jan 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Jan 25
